Completing your purchase

Purchase successful!

Finish signing up to access your purchase

Or login with Facebook to sign in:

Sorry, this film can not be watched from your country.

Our wish at Reelhouse is for its content to be available world wide.
Certain criteria must be met before this can be made a reality, and we are working
hard to make this happen. We want this as badly as you do. Stay tuned!

n2n

Directed by mikki2013

Details

A Mind-Blowing Documentary about the resurgence of psychedelics as medicines

Through interviews with the world’s foremost researchers, writers, psychologists and pioneers in psychedelic psychotherapy, Neurons to Nirvana explores the history of five powerful psychedelic substances (LSD, Psilocybin, MDMA, Ayahuasca and Cannabis) and their now established medicinal potential.

Several well-respected researchers are conducting clinical trials to treat a range of afflictions: PTSD, addictions and the psychological stresses suffered by late-stage terminal cancer patients. The initial results of all these studies are remarkable.

The story extends beyond these trials however. Clients of licensed therapists are using psychedelics not as escape routes or addictive crutches, but in a quest for transformation, mental health, creativity, intellectual and spiritual enhancement and insight.

For the first time in two generations, the use of these drugs is not being presented as harmful or as self-indulgent, but as a rational and valuable addition to therapeutic practice.

No credits listed.

No music listed.

No equipment listed.

Latest Updates

2
Videos

3 Images

Store

n2n

A Mind-Blowing Documentary about the resurgence of psychedelics as medicines

Through interviews with the world’s foremost researchers, writers, psychologists and pioneers in psychedelic psychotherapy, Neurons to Nirvana explores the history of five powerful psychedelic substances (LSD, Psilocybin, MDMA, Ayahuasca and Cannabis) and their now established medicinal potential.

Several well-respected researchers are conducting clinical trials to treat a range of afflictions: PTSD, addictions and the psychological stresses suffered by late-stage terminal cancer patients. The initial results of all these studies are remarkable.

The story extends beyond these trials however. Clients of licensed therapists are using psychedelics not as escape routes or addictive crutches, but in a quest for transformation, mental health, creativity, intellectual and spiritual enhancement and insight.

For the first time in two generations, the use of these drugs is not being presented as harmful or as self-indulgent, but as a rational and valuable addition to therapeutic practice.